In this episode, Professor Konstantin Slavin reads aloud an article by Alexander Thorpe, Quentin F. Gronau, and Garston Liang which explores the various types of data and the appropriate statistical tests for each. Understanding data types is crucial for designing studies and analyzing data accurately. Key points include:

In this episode, Prof. Konstantin Slavin reads aloud an article by Garston Liang, Quentin F. Gronau, and Alexander Thorpe which addresses the use of N-of-1 trials in neuromodulation and personalized medicine. N-of-1 trials are a powerful method for investigating treatment effects on an individual basis, making them ideal for patients with stable symptoms and chronic disorders.Key points covered include:- N-of-1 Trial Design: Involves repeated cycles of treatment and placebo, with the patient serving as their own control.- Personalization: Tailors treatment decisions to individual outcomes, offering a high level of evidence for treatment efficacy.- Double-Blinding: Ensures both patient and clinician are unaware of the treatment phase to maintain objectivity.- Crossover Design: Alternates between treatment and placebo phases, often randomized to prevent time-related biases.- Wash-In/Out Periods: Important for avoiding carry-over effects, especially in pharmaceutical interventions.The article also highlights the statistical considerations for analyzing N-of-1 trials, emphasizing the importance of proper design and analysis to ensure valid conclusions. Tune in to learn how N-of-1 trials can enhance personalized treatment strategies in neuromodulation and beyond.

Resources:

In this episode, Professor Konstantin Slavin reads aloud an article by Quentin F. Gronau, Garston Liang, and Alexander Thorpe on how to interpret risk ratios, odds ratios, and hazard ratios in clinical studies. These measures are crucial for understanding the effectiveness of treatments and the association between risk factors and outcomes.

Key points include:

The article also discuss common misconceptions, such as misinterpreting odds ratios as risk ratios and hazard ratios as risk ratios, and provide practical advice for accurate interpretation.

Join us to gain a clearer understanding of these essential statistical tools and their applications in medical research.

In this episode, Prof. Konstantin Slavin provides a live reading of a paper produced by Quentin F. Gronau, Garston Liang, and Alexander Thorpe that explore Bayes factors as an alternative to p-values for hypothesis testing. They explain how Bayes factors (BF10) measure evidence for an effect versus no effect, with BF10 > 1 indicating evidence for an effect, and BF10 < 1 indicating evidence against it.

The discussion highlights the advantages of Bayes factors, such as quantifying evidence for both the null and alternative hypotheses and allowing for continuous evidence monitoring. Using simple analogies, the article provides clear guidance on interpreting Bayes factors and address common misconceptions.

Join us to discover how Bayes factors can improve your understanding and interpretation of statistical data.

Season 1 Episode 5 of the show is available wherever you get your podcasts!

➕ Neuromodulation for Neuropathic Pain ➕

Join us as Dr. Dalia Elmofty, Associate Professor of Anesthesia and Critical Care at UChicago Medicine, delves into the transformative role of neuromodulation in the treatment of neuropathic pain.

Neuropathic pain is characterized by a disarray in pain processing and presents unique challenges. Dr. Elmofty explains how neuromodulation offers a groundbreaking approach by precisely targeting specific areas, minimizing the side effects typically associated with pharmacological methods.

Tune in now to learn about the practical challenges and considerations in implementing neuromodulation therapies and the potential of emerging technologies to further enhance patient outcomes!

Dr. Alexios Carayannopoulos discusses the field of neurorehabilitation and its intersection with neuromodulation, addressing topics including his approach to multidisciplinary care and the importance of effective communication between specialists, accessibility of care, the impact of cultural barriers on patient outcomes, the process of device implant trials, and the potential role of artificial intelligence (AI) in the future of the field.

Dr. Lisa Goodman, assistant professor and FWO postdoctoral researcher, discusses the importance of statistics in the medical field. Statistics is important in every facet of medicine, from evaluating the safety of new therapies to comparing treatment options in clinical trials.

We explore the role of statistics in evidence-based medicine and precision medicine and offer guidance for clinicians to improve their understanding of statistical data to help make informed decisions and develop prediction models for personalized patient care.

Dr. Heather Pinckard-Dover, a neurosurgeon specializing in neuromodulation, shares her personal journey and passion for the field, offering insight for clinicians considering neuromodulation for their career path. She discusses the immediate impact and rewards of neuromodulation in improving patients' lives while also highlighting challenges such as U.S. insurance coverage and the importance of patient selection.

Neuromodulation is the interface between the nervous system and technology, and this episode explores how it can be used to treat a wide range of conditions and how patients can benefit. From awareness and accessibility to common misconceptions and his hope for the future of the field, this episode features Professor Lawrence Poree, MD, PhD, MPH, who addresses the importance of raising awareness about neuromodulation, as it is not widely taught in medical schools, which leads to a lack of awareness among both patients and physicians.

Welcome to The Neuromodulation Podcast, presented to you by the International Neuromodulation Society. Dive into the forefront of today’s emerging neuromodulation techniques, insights, and ethical and clinical applications. Subscribe now to join the multidisciplinary collaboration of medical care providers, scientists, and engineers who are part of the global conversation that’s shaping the future of healthcare.